Articles

Results 1 to 5 of 66


Ukraine: the law on canceling marketing authorizations due to ties with Russian/Belarusian pharmaceutical manufacturing became effective

Belarus, Russia, Ukraine - June 20 2022 On 8 June 2022, Law No. 2271-IX (“Law“) became effective. This Law expects to prevent the turnover of pharmaceuticals manufactured in Russia or…

Olha Sviatenka

Ukraine: Cancellation of marketing authorizations for pharmaceuticals manufactured in Russia or Belarus or held by companies affiliated or otherwise related to those with manufacturing facilities in Russia or Belarus

Belarus, Russia, Ukraine - May 25 2022 On 22 May 2022, the Parliament of Ukraine adopted draft law no. 7313 (“Draft Law“) aiming to prevent the turnover of pharmaceuticals manufactured in…

Olha Sviatenka

Spotlight: an introduction to M&A in Ukraine

Ukraine - December 21 2021 This article provides a general introduction to M&A in Ukraine, including an overview of recent activity and a summary of the legal framework governing M&A transactions.

Viacheslav Yakymchuk

Insight: competition law implications of M&A transactions in Ukraine

Ukraine - December 21 2021 An overview of the competition law implications of M&A transactions in Ukraine, including merger review procedures.

Viacheslav Yakymchuk

Ukraine: Conducting Business in Ukraine 2021

Ukraine - June 6 2021 This handbook Conducting Business in Ukraine 2021 has been prepared by the attorneys of Baker McKenzie’s Kyiv office as a general guide for companies…

Serhiy V. Chorny, Ruslan Drobyazko, Maksym Hlotov, Mariana Marchuk, Andrii Moskalyk, Lina Nemchenko, Serhiy Piontkovsky, Hanna Shtepa, Oksana A. Simonova, Ihor Siusel, Oleksiy Stolyarenko, Hennadiy Voytsitskyi, Viacheslav Yakymchuk